BI 655088

BI 655088 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 655088, covering 2023-01-25 to 2023-01-25. Get the full timeline:

Most recent: Clinical Trial Update: Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male Volunteers [Phase 1]